CAS: 229970-69-8 - Carbamic acid, [4-[[(4-fluorophenyl)methyl]amino]-2-(β-<span class="text-smallcaps">D</span>-glucopyranosylamino)phenyl]-, ethyl ester
Formula:C22H28FN3O7
InChI:InChI=1S/C22H28FN3O7/c1-2-32-22(31)26-15-8-7-14(24-10-12-3-5-13(23)6-4-12)9-16(15)25-21-20(30)19(29)18(28)17(11-27)33-21/h3-9,17-21,24-25,27-30H,2,10-11H2,1H3,(H,26,31)/t17-,18-,19+,20-,21-/m1/s1
InChI key:InChIKey=QJZGGFBXRVPPEE-YMQHIKHWSA-N
SMILES:O=C(OCC)NC1=CC=C(C=C1NC2OC(CO)C(O)C(O)C2O)NCC3=CC=C(F)C=C3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Retigabine N-β-D-Glucoside REF: TR-R189065CAS: 229970-69-8 | - - - | 3,559.00 € | Mon 13 Jan 25 | |
Retigabine N-β-D-glucoside REF: 3D-EJA97069CAS: 229970-69-8 | Min. 95% | - - - | Discontinued product |
Retigabine N-β-D-Glucoside
Controlled ProductRef: TR-R189065
50mg | 3,559.00 € |
Retigabine N-β-D-glucoside
Ref: 3D-EJA97069
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |